The objective of this study is to evaluate the antimalarial property of Carica papaya L. leaf extracts and the cytotoxicity of active samples. C. papaya leaves were extracted and screened against Plasmodium falciparum 3D7 and Dd2 strains. Bioassay-guided fractionation was carried out. The dichloromethane extract of C. papaya leaves showed significant antiplasmodial activity against P. falciparum 3D7 and Dd2. Successful bioassay-guided fractionation afforded a fraction three to seven times more active than the dichloromethane extract. Carpaine was isolated from the most active alkaloidal extract and identified in the active fraction and dichloromethane leaf extract. The cytotoxicity of active samples was evaluated against NL20 cells. A haemolysis assay was performed on carpaine. Carpaine exhibited good activity against both strains of P. falciparum with IC 50 of 2.01 ± 0.18 μg/mL (4.21 µM) and 2.19 ± 0.60 μg/mL (4.57 µM) against 3D7 and Dd2 strains respectively. It exhibited high selectivity for the parasite and was non-toxic to healthy uninfected human red blood cells. This is the first study investigating the haemolysis potential of carpaine. The results provide a scientific basis for the traditional use of C. papaya leaves for malaria treatment. More work is required to evaluate the efficacy and safety of carpaine for further development into potential new antimalarial drugs.
Several studies have investigated the antimalarial properties of C. papaya extracts but only two papers have reported the isolation of active compounds. The ethanol extract of C. papaya leaves obtained from Soxhlet extraction inhibited growth of chloroquine-sensitive and chloroquine-resistant P. falciparum (strains not specified) [7] . IC 50 of the leaf extract obtained by cold ethanolic percolation was 46.23 µg/mL (strain of P. falciparum not specified) [8] . Melariri et al. [9] sequentially extracted C. papaya leaves and found that the ethyl acetate extract obtained from sequential extraction was active against a chloroquine-sensitive D10 strain of P. falciparum (IC 50 2.6 μg/mL). The aqueous extract was not active. Linoleic and linolenic acids were subsequently isolated from the most active fraction, with IC 50 values of 6.88 μg/mL (24.5 μM) and 3.58 μg/mL (12.9 μM) respectively. It is noted that the activity of these two compounds were much lower than the ethyl acetate extract. The isolation of carpaine from C. papaya leaves was reported and it was found to possess antiplasmodial activity in vitro and in vivo, although its efficacy in a P. berghei ANKA mouse model using the 4-day suppression assay brought about a suboptimal reduction in parasitaemia when carpaine was administered intraperitoneally at a daily dose of 5 mg/kg [10] . The objective of the current study was to evaluate the antimalarial activity and cytotoxicity of C. papaya leaves by performing bioassay-guided fractionation on the active extract, assessing the antiplasmodial activity against two strains of P. falciparum and cytotoxicity of the active extract, fraction and active compound using NL20 (human bronchial epithelial) cells. The effects of the active compound on uninfected red blood cells (RBCs) were evaluated. The alkaloid carpaine was isolated from the most active alkaloidal extract and detected in the active fraction of C. papaya dichloromethane (DCM) leaf extract. It was further characterized and its antiplasmodial activity, selectivity for P. falciparum and toxicity in RBCs determined.
Antimalarial activity of C. papaya leaf extracts, fractions and carpaine: Of the extracts obtained from C. papaya leaves, the most active extract was the alkaloidal hexane extract (IC 50 3.43 ± 0.41 and 1.52 ± 0.003 µg/mL against 3D7 and Dd2 strains respectively), followed by the DCM leaf extract (IC 50 7.67 ± 1.9 and 4.50 ± 0.17 µg/mL against 3D7 and Dd2 strains respectively). The leaf juice at a dilution of 1/64 inhibited 50% growth of P. falciparum 3D7 and the ethyl acetate leaf extract was moderately active with IC 50 20.32 ± 3.5 µg/mL. All the other extracts were not significantly active. The alkaloidal hexane extract and DCM extract were therefore subjected to further fractionation and subsequent studies in this work.
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From the alkaloidal hexane extract, carpaine ( Figure 1 ) was isolated and its identity confirmed by comparison with the NMR, MS, FT-IR, and X-ray crystal data from existing literature [11, 12] . It was found to have good antimalarial activity when screened against both P. falciparum 3D7 and Dd2 strains (IC 50 2.01 ± 0.18 µg/mL, 95% CI [1.56,2.46 µg/mL] (4.21 ± 0.38 µM) and 2.19 ± 0.60 µg/mL, 95% CI [0.70,3.68 µg/mL] (4.57 ± 1.25 µM) against 3D7 and Dd2 strains respectively). It is three to five times more active than the crude DCM extract of C. papaya (IC 50 7.67 ± 1.88 and 4.50 ± 0.17 µg/mL against 3D7 and Dd2 strains respectively). Bioassay-guided fractionation of the DCM extract resulted in 25 pooled fractions, of which only one pooled fraction (177-184) which eluted with 15 -20% methanol in DCM showed significant activity against P. falciparum 3D7, with IC 50 of 1.03 ± 0.14 and 2.98 ± 0.04 µg/mL against 3D7 and Dd2 strains respectively, which was about three to seven times more active than the DCM extract. The IC 50 of chloroquine against 3D7 and Dd2 strains are 1.28 ± 0.14 x 10 -2 µg/mL (24.37 ± 2.71 nM) and 0.16 ± 0.04 µg/mL (0.31 ± 0.08 µM) respectively, while IC 50 of artesunate against 3D7 and Dd2 strains are 6.93 ± 1.11 x 10 -4 µg/mL (1.80 ± 0.29 nM) and 2.11 ± 0.68 x 10 -3 µg/mL (5.48 ± 1.77 nM) respectively. Carpaine was identified in the active fraction and dichloromethane leaf extract using LC-MS (data not shown). The antimalarial activity of carpaine is consistent with that reported by Julianti et al. who tested carpaine against P. falciparum K1 (resistant to chloroquine and pyrimethamine), although the compound did not prolong survival times in P. berghei-infected mice [10] . It should also be noted that there are reports showing differing susceptibilities between P. falciparum and P. berghei to some compounds, such as the natural products cryptolepine and berberine. These alkaloids have been reported to be active against P. falciparum in vitro but were inactive in P. berghei-infected mice [13, 14] . One plausible reason could be that the rodent model may not be suitable to demonstrate the expected activity [15] . More than one in vivo model may be required for adequate evaluation of the active compound. Screening the compound against clinical Plasmodium isolates is recommended to further assess its efficacy. The good activity of the pooled fraction suggests that further work to identify other potential antimalarial components in the pooled fraction and to elucidate any potential synergy between the components is warranted.
Cytotoxicity and selectivity of active samples from C. papaya and carpaine: A cytotoxicity study was performed to determine the selectivity of samples that have antiplasmodial activity. Table 1 shows the cytotoxicity assay results and selectivity indices of active samples from C. papaya. The extract and fraction displayed moderate to high selectivity respectively. Carpaine displayed a high selectivity index (SI) of 128. The high selectivity of carpaine is in agreement with a previous report [10] of IC 50 of 21.5 µM against L6 (rat skeletal myoblast) cells and a corresponding SI of 107.5. Incorporation of an SI allows for a more qualitative assessment of compounds that are genuinely promising as antimalarial leads [16] .
In general, a true pharmacological effect is distinguished from nonselective toxicity when SI > 10 [17, 18] . These results suggest that the antimalarial activity of carpaine is possibly due to a direct inhibitory action on parasite rather than non-selective toxicity to host and target cells.
Haemolysis evaluation of carpaine: Table 2 shows the results of the haemolysis assay, normalized to 100% lysis in the positive control. Carpaine did not cause significant haemolysis at the concentrations tested, including the highest concentration of 0.1 mg/mL which is more than 50 times its IC 50 . Visual inspection of the well plates indicated that treatment with carpaine had similar effects as untreated RBCs since in both cases, the RBCs formed a pellet at the bottom of the well with clear colourless supernatant. In the positive control, the supernatant was red and there was no pellet formed due to RBC lysis. These results suggest that the antiplasmodial activity of carpaine is not due to RBC lysis but a real inhibitory action on the Plasmodium parasite instead. This is the first study showing the non-toxicity of the antimalarial compound, carpaine, on normal uninfected human RBCs. In view of these results, carpaine is a promising lead compound for further development, given its good activity against both strains of P. falciparum, high selectivity and non-toxicity to RBCs. The in vitro screening of carpaine against field isolates, elucidating the mechanism of action, evaluating the selectivity of carpaine for the Plasmodium parasite using a variety of host cells and structureactivity relationships should be investigated to further evaluate carpaine and its derivatives for the development of new antimalarial agents.
Other pharmacological activities of carpaine: Carpaine has demonstrated antithrombocytopenic activity, improved haemodynamic response, lowering of blood pressure and smooth muscle relaxation in animal models, and antimicrobial activities [11, [19] [20] [21] [22] . The Merck Index specified an oral dose of carpaine hydrochloride at 10 -20 mg/day and injectable dose of 6 -10 mg/day for mitral insufficiency and aortic stenosis [23] . Although the antimalarial activity of carpaine has been recently reported, the mechanism and site of action of carpaine are still unknown and present an area worthy of further investigation.
In a clinical trial that investigated the effects of capsules of 70% ethanolic extract of C. papaya leaves on platelet count and haematocrit in 80 patients with dengue fever in Indonesia, the intervention group (extract with standard care) showed faster recovery in platelet count and shorter hospital stay compared to the control group (only standard care) [24] . However, adverse effects, if any, were not reported. In an in vivo study in rats, no histologic and serum biochemical abnormalities were observed after carpaine was dosed at 2 mg/kg [11] . Despite the absence of toxicity reported, more studies are required to determine the clinical efficacy and safety of the traditional C. papaya leaf decoction in patients with malaria and for complete toxicity assessment of carpaine.
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In conclusion, the results provide a scientific basis for the use of C. papaya leaves for malaria and further confirms the antimalarial activity of carpaine. This work has also shed new light on the cytotoxicity and preclinical safety of carpaine. Carpaine exhibited good activity against both strains of P. falciparum. It displayed a high selectivity for the parasite and is non-toxic to normal human RBCs. Carpaine holds promise for further development as an antimalarial lead compound. Further work to evaluate its efficacy and safety in humans is warranted.
Experimental
Plant materials and identification: C. papaya was identified with reference to Singapore National Parks Board (NParks) Flora & Fauna Web [25] and New Crop Resource Online Programme [26] . C. papaya leaves were collected from a local community herbal garden (Jurong West Community Garden). A botanically identified voucher specimen was deposited in the herbarium at Department of Pharmacy, National University of Singapore. Leaves were washed with water, dried manually with tissue, and blended using a blender before extraction.
Extraction: C. papaya leaves were extracted fresh. 77.6 g of leaves were used to squeeze out 20 mL of juice using a metal squeezer. 100.4 g of leaves were decocted for 30 min in 400 mL of water. 206.9 g of leaves were sequentially extracted with hexane, DCM, ethyl acetate, and methanol (400 mL x 3 cycles of ultrasonication, 30 min each).
The sequential extraction procedure was subsequently scaled up for further work using 897.4 g of leaves.
Extracts obtained by decoction and sequential extraction were filtered and evaporated to dryness at 40-46°C. For alkaloidal extraction, 612.7 g of leaves were extracted using a reported method [27] . The crude alkaloidal extract was obtained by extracting in hexane. Colourless cubes were obtained by re-crystallization with acetone.
Fractionation of C. papaya extract:
The DCM extract was subjected to column chromatography over silica gel. Fractions were eluted from the column by gradient elution starting with 100% hexane, to 100% DCM, and thereafter to 30% methanol. The elution of fractions was monitored using TLC and similar fractions were pooled. Fractions were subsequently screened for antimalarial activity.
Yields of C. papaya leaf extracts: Extraction using polar solvents such as methanol and water resulted in greater yields (3.14% w/w, and 6.86% w/w respectively) compared to using less polar extracts such as hexane, DCM and ethyl acetate (0.23% w/w, 0.65 % w/w, and 0.78% w/w respectively). Similarly, from alkaloidal extraction, the aqueous basified extract gave the highest yield (7.74% w/w), while the defatted hexane extract pre-alkaloidal extraction and crude alkaloidal hexane extract were of lower yields (0.005% w/w, and 0.07% w/w respectively).
Plasmodium falciparum culture, synchronization and cryopreservation: P. falciparum laboratory strains 3D7 (chloroquine-sensitive) and Dd2 (chloroquine-, quinine-, pyrimethamine-, and sulfadoxineresistant) were maintained in the Singapore Immunology Network, A*STAR, Singapore. Parasites were thawed and grown in leukocyte-depleted RBCs at 2% haematocrit at 37°C at controlled conditions (3% oxygen, 4% carbon dioxide, and 93% nitrogen), in RPMI 1640 tissue culture medium supplemented with 50 µg/mL hypoxanthine, 25 mM HEPES, 0.3 g/L L-glutamine, 11 mM glucose, 25 mM NaHCO 3 , 2.5 µg/mL gentamicin, and 0.5% w/v Albumax II. RBCs used for culture were obtained from blood drawn from anonymized donors recruited in the Singapore Immunology Network, IRC. Ethics approval was obtained from the Institutional Review Board, National University of Singapore (IRB protocol reference: 10-250). Parasites were synchronized using sorbitol treatment. The ring stages of P. falciparum were cryopreserved according to an adapted method from Kosaisavee et al. [28] .
Drug sensitivity assay: Antimalarial activity was tested against P. falciparum 3D7 and Dd2 strains using a protocol modified from the World Health Organization microtest [29] . For preliminary screening of plant extracts, fractions and compounds, a single concentration of 42 µg/mL of extract dissolved in methanol was used in the drug sensitivity assay. IC 50 were determined for samples which showed total growth inhibition at the end of the incubation period. Seven concentrations of serial dilutions (two-fold) of each sample were added on the 96-well pre-dosed drug plates. In both cases, artesunate and chloroquine were used as the positive controls, with maximum concentrations of 19 ng/mL for artesunate, and 308.7 ng/mL (3D7) or 5952.5 ng/mL (Dd2) for chloroquine. Independent triplicates were performed for IC 50 determination.
Two hundred microlitres of a 2% haematocrit blood medium mixture consisting of RPMI 1640, 40 mg/mL gentamicin sulphate, 25 mM HEPES, 11 mM glucose, 200 µM hypoxanthine, and 0.5% w/v Albumax II was added to each well of plates pre-dosed with the extracts. The parasites were cultured continuously in vented culture flasks in a gas chamber at 37°C with 5% CO 2 until they reached mature stage. Incubation was stopped and the plates were harvested when 85% of ring stage parasites had reached the mature schizont stage in the drug-free control.
Thick blood smears were made from each well and stained with 5% Giemsa solution for 15 min, and examined microscopically. The average number of schizonts (defined as parasites with five or more chromatin dots visible under microscopy) remaining at the end of the 42-48 hour incubation period per 100 parasites in each well was determined by microscopy, and normalized to those in the control wells. Ring stage parasites and gametocytes were not included in the count. The dose-response curves were analyzed using nonlinear regression analysis, and the concentration which inhibited 50% growth (IC 50 ) was derived using an inhibitory sigmoid E max model [30] . Each reported IC 50 value is the mean ± standard deviation (SD) from three independent experiments.
WST-1 cytotoxicity assay:
The active extract, fraction, isolated compound and chloroquine were prepared at 1 mg/mL while artesunate was prepared at 0.067 mg/mL. Serial dilutions were performed using RPMI supplemented with 10% foetal bovine serum. The final concentration of DMSO for all test samples was not more than 0.4%.
Cytotoxicity was determined using the WST-1 assay. Exponentially growing NL20 cells were plated in 96-well plates at an optimized cell density of 3.5 x 10 4 cells/100 µl. The adherent cells were incubated overnight at 37°C and 5% CO 2 to allow attachment. After 48 h of treatment with test samples, the media were aspirated and replaced with 10% v/v WST-1 in complete media. The plates were incubated for 30 min. The absorbance in each well was quantitated at 440 nm against a reference wavelength of 650 nm using a microplate reader.
Cell viability was expressed as a percentage of the vehicle control. Artesunate and chloroquine were used as positive controls. The CC 50 values were determined using GraphPad Prism 6. Each reported value is the mean ± SD from three independent experiments. The SI was determined by taking the ratio of IC 50 values against P. falciparum and CC 50 against NL20 cells.
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Haemolysis assay:
The toxicity of carpaine in uninfected host RBCs evaluated using a haemolysis assay, according to Sarkar et al. [31] with some modifications. Freshly obtained RBCs were washed thrice with PBS (pH 7.4). The haemolysis assay was performed at 2% hematocrit with two-fold serial dilutions from 111 µg/mL of test compounds in a final volume of 200 µl, followed by incubation at 37°C for 1 h. 1% Triton-X (v/v) was used as a positive control. Non-specific haemolysis was corrected for by using untreated RBCs as negative control. After incubation, the plates were centrifuged at 2000 rpm for 5 min and the absorbance of the supernatant was measured at 540 nm. The percentage of haemolysis was calculated as follows: [(Optical density (OD) 540 of sample -OD 540 PBS)/(OD 540 of 1 % Triton X-100 -OD 540 PBS)] × 100. Compounds were tested in triplicates. Ethics approval for this study was obtained from the Institutional Review Board, National University of Singapore (IRB protocol reference: B-14-056).
